| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e071d18fea054bf8d1420d483e78ed1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 |
| filingDate |
2014-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86f49e6b4475faf2df0348d4b71b3a54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9bf236a47ef7fa6db64255c4d98579d |
| publicationDate |
2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014145970-A1 |
| titleOfInvention |
Modulation of regulatory t cells via g-coupled protein receptor 43 |
| abstract |
Disclosed herein are compositions and methods that are useful for inducing the development of regulatory T cells (T reg ). Such compositions and methods are useful for treating inflammatory conditions and in particular inflammatory conditions affecting the gastrointestinal tract of a subject. In certain embodiments, the present inventions generally relate to short chain fatty acids and the discovery that such short chain fatty acids may be used to treat and/or prevent inflammatory conditions by enhancing the size and immune function of a subject's endogenous T reg population. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105329-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020073087-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389493-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9770435-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10744166-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3209381-B1 |
| priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |